Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marcea Bland Lloyd Insider Profile
4 Followers
Marcea Bland Lloyd, Director at Poseida Therapeutics, holds 68.95K shares in Poseida Therapeutics (Ticker: PSTX).
Marcea Bland Lloyd has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Marcea Bland Lloyd's holdings
Insider Roles
Director
Roles that Marcea Bland Lloyd holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 15, 2020 - Jul 15, 2021
Return:-39.00%
The most profitable trade made by Marcea Bland Lloyd
Marcea Bland Lloyd's Trading History
List of latest transactions for each holding click on a transaction to see Marcea Bland Lloyd's performance on stock
You May Also Like
Marcea Bland Lloyd insider profile FAQ
What is the percentage of profitable transactions made by Marcea Bland Lloyd?
The percentage of profitable transactions made by Marcea Bland Lloyd is ―.
What is the average return per transaction made by Marcea Bland Lloyd?
The average return per transaction made by Marcea Bland Lloyd is ―.
What stocks does Marcea Bland Lloyd hold?
Marcea Bland Lloyd holds: PSTX stocks.
What was Marcea Bland Lloyd’s latest transaction?
Marcea Bland Lloyd latest transaction was an Uninformative Buy of ―.
What was Marcea Bland Lloyd's most profitable transaction?
Marcea Bland Lloyd’s most profitable transaction was an Informative Buy of PSTX stock on July 15, 2020. The return on the trade was -39.00%.
What is Marcea Bland Lloyd's role in Poseida Therapeutics?
Marcea Bland Lloyd's role in Poseida Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.